Spain increases AstraZeneca dose gap to 16 weeks as it diverges from EU regulator advice
- Date: 01-May-2021
- Source: The National
- Sector:Economy
- Country:Saudi Arabia
Spain increases AstraZeneca dose gap to 16 weeks as it diverges from EU regulator advice
Spain is extending the gap between the first and second doses of AstraZeneca's Covid-19 vaccine to 16 weeks for people aged under 60, the government said on Friday.
The country is the first to promote "off-label use" and to diverge from the European Medicines Agency's (EMA) usage authorisation.
The move is not approved by the regulator and it would make Spain responsible for any possible side effects.
Select Sector 
Select Country 
